Continued circulatory support: effect of epinephrine or dopamine on 24-hour survival and neurologic function in dogs
dc.contributor.author | Natale, JoAnne E. | en_US |
dc.contributor.author | D'Alecy, Louis G. | en_US |
dc.date.accessioned | 2006-04-07T20:48:21Z | |
dc.date.available | 2006-04-07T20:48:21Z | |
dc.date.issued | 1989-06 | en_US |
dc.identifier.citation | Natale, Joanne E., D'alecy, Louis G. (1989/06)."Continued circulatory support: effect of epinephrine or dopamine on 24-hour survival and neurologic function in dogs." Resuscitation 17(3): 273-286. <http://hdl.handle.net/2027.42/27916> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T19-4C06HWD-2P/2/2b733c8b1dfcd404a9ef7f93fc7c82ed | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/27916 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2548272&dopt=citation | en_US |
dc.description.abstract | The effects on 24-h survival and neurologic function were compared following continued postresuscitation circulatory support with epinephrine or dopamine. Cardiopulmonary arrest was induced by ventricular fibrillation. After 10 min, resuscitation efforts were initiated including i.v. infusion of either epinephrine (6 [mu]g/kg per min, 11 dogs) or dopamine (10 [mu]g/kg per min, 14 dogs) for continued circulatory support. There was no difference detected in duration of circulatory support, although dogs receiving epinephrine required more lidocaine (3.3 +/- 0.4 vs. 1.8 +/- 0.3 mg/kg, P = 0.005). Likewise, there was no statistically significant difference detected in MAP or HR between groups at any time tested. However, dogs receiving epinephrine had significantly worse neurologic function at 6 and 12 h postarrest. Mean survival time (20.3 +/- 1.2 vs. 15.3 +/- 1.9 h, P = 0.028) and overall survival (P = 0.027, survival curve analysis) were significantly longer for dogs receiving dopamine. Plasma glucose in the first 6 h postarrest was significantly higher in dogs receiving epinephrine (P = 0.006). These results suggest that the use of epinephrine for continued vasopressor support in cardiopulmonary resuscitation may contribute to decreased survival and poorer neurologic function in this controlled experimental setting. It is reasonable to propose that similar responses to these commonly used circulatory support agents occur clinically. Therefore, continued vasopressor support with dopamine rather than epinephrine may be justified in the setting of cardiac resuscitation. | en_US |
dc.format.extent | 1000158 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Continued circulatory support: effect of epinephrine or dopamine on 24-hour survival and neurologic function in dogs | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Family Medicine and Primary Care | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Surgery, The University of Michigan Medical School M7744 Medical Science II, 1301 Catherine Street, Ann Arbor, MI 48109-0622, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Physiology, The University of Michigan Medical School M7744 Medical Science II, 1301 Catherine Street, Ann Arbor, MI 48109-0622, U.S.A. | en_US |
dc.identifier.pmid | 2548272 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/27916/1/0000339.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0300-9572(89)90043-9 | en_US |
dc.identifier.source | Resuscitation | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.